Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 9
1951 3
1952 1
1953 1
1955 1
1956 2
1958 5
1959 12
1960 10
1961 12
1962 11
1963 7
1964 7
1965 12
1966 10
1967 11
1968 17
1969 15
1970 17
1971 19
1972 12
1973 18
1974 16
1975 15
1976 26
1977 17
1978 24
1979 31
1980 37
1981 41
1982 22
1983 40
1984 39
1985 72
1986 69
1987 76
1988 69
1989 80
1990 88
1991 90
1992 98
1993 81
1994 92
1995 94
1996 106
1997 94
1998 109
1999 113
2000 107
2001 119
2002 96
2003 117
2004 110
2005 153
2006 153
2007 129
2008 159
2009 166
2010 181
2011 181
2012 202
2013 196
2014 156
2015 186
2016 186
2017 203
2018 209
2019 190
2020 244
2021 307
2022 135
Text availability
Article attribute
Article type
Publication date

Search Results

5,279 results
Results by year
Filters applied: . Clear all
Page 1
B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity.
Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, Nakano R, Hatae R, Menzies RJ, Sonomura K, Hojo N, Ogawa T, Kobayashi W, Tsutsui Y, Yamamoto S, Maruya M, Narushima S, Suzuki K, Sugiya H, Murakami K, Hashimoto M, Ueno H, Kobayashi T, Ito K, Hirano T, Shiroguchi K, Matsuda F, Suematsu M, Honjo T, Fagarasan S. Zhang B, et al. Among authors: ogawa t. Nature. 2021 Nov;599(7885):471-476. doi: 10.1038/s41586-021-04082-1. Epub 2021 Nov 3. Nature. 2021. PMID: 34732892 Free PMC article.
Immunotherapy for squamous cell carcinoma of the head and neck.
Yokota T, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ogawa T, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y, Hayashi R; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Yokota T, et al. Among authors: ogawa t. Jpn J Clin Oncol. 2020 Sep 28;50(10):1089-1096. doi: 10.1093/jjco/hyaa139. Jpn J Clin Oncol. 2020. PMID: 32776100 Review.
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, Mutoh Y, Homma Y, Terada M, Ogawa T, Kashizaki F, Yokoyama T, Koba H, Kasahara H, Yokota K, Kato H, Yoshida J, Kita T, Kato Y, Kamio T, Kodama N, Uchida Y, Ikeda N, Shinoda M, Nakagawa A, Nakatsumi H, Horiguchi T, Iwata M, Matsuyama A, Banno S, Koseki T, Teramachi M, Miyata M, Tajima S, Maeki T, Nakayama E, Taniguchi S, Lim CK, Saijo M, Imai T, Yoshida H, Kabata D, Shintani A, Yuzawa Y, Kondo M. Doi Y, et al. Among authors: ogawa t. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01897-20. doi: 10.1128/AAC.01897-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32958718 Free PMC article. Clinical Trial.
Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.
Inoue M, Tanboon J, Hirakawa S, Komaki H, Fukushima T, Awano H, Tajima T, Yamazaki K, Hayashi R, Mori T, Shibuya K, Yamanoi T, Yoshimura H, Ogawa T, Katayama A, Sugai F, Nakayama Y, Yamaguchi S, Hayashi S, Noguchi S, Tachimori H, Okiyama N, Fujimoto M, Nishino I. Inoue M, et al. Among authors: ogawa t. JAMA Neurol. 2020 Jul 1;77(7):872-877. doi: 10.1001/jamaneurol.2020.0673. JAMA Neurol. 2020. PMID: 32310254 Free PMC article.
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes.
Nishida M, Yamashita N, Ogawa T, Koseki K, Warabi E, Ohue T, Komatsu M, Matsushita H, Kakimi K, Kawakami E, Shiroguchi K, Udono H. Nishida M, et al. Among authors: ogawa t. J Immunother Cancer. 2021 Sep;9(9):e002954. doi: 10.1136/jitc-2021-002954. J Immunother Cancer. 2021. PMID: 34531248 Free PMC article.
Macrophages in lung fibrosis.
Ogawa T, Shichino S, Ueha S, Matsushima K. Ogawa T, et al. Int Immunol. 2021 Nov 25;33(12):665-671. doi: 10.1093/intimm/dxab040. Int Immunol. 2021. PMID: 34270737 Free PMC article. Review.
Loricrin Protects against Chemical Carcinogenesis.
Ogawa T, Ishitsuka Y, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M, Roop DR, Nomura T. Ogawa T, et al. J Invest Dermatol. 2021 Dec 27:S0022-202X(21)02632-4. doi: 10.1016/j.jid.2021.12.015. Online ahead of print. J Invest Dermatol. 2021. PMID: 34968502 Free article. No abstract available.
5,279 results